Insulet (PODD) EPS (Basic) Growth (5y) (2015 - 2025)
Insulet (PODD) EPS (Basic) Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn |
| 10 | Insulet | 11.56 Bn | 11.07 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.52% |
| Sep 30, 2025 | 47.80% |
| Jun 30, 2025 | 7.40% |
| Mar 31, 2025 | 76.50% |
| Dec 31, 2024 | 77.09% |
| Sep 30, 2024 | 142.53% |
| Jun 30, 2024 | 158.34% |
| Mar 31, 2024 | 58.27% |
| Dec 31, 2023 | 54.53% |
| Sep 30, 2023 | 92.51% |
| Jun 30, 2023 | 73.27% |
| Mar 31, 2023 | 38.22% |
| Dec 31, 2021 | 273.44% |
| Sep 30, 2021 | 177.96% |
| Jun 30, 2021 | -169.48% |
| Dec 31, 2020 | -5.61% |
| Sep 30, 2020 | 66.12% |
| Jun 30, 2020 | 47.26% |
| Mar 31, 2020 | -6.27% |
| Dec 31, 2019 | 35.06% |